March 16, 2026
4 MIN READ
ORNL goes all in on targeted alpha therapy
ORNL is advancing cancer treatment by developing medical radioisotopes and leading research to improve targeted alpha therapies and theranostics. Researchers are designing advanced chelators and nanoparticles while using artificial intelligence and quantum simulations to better understand radioisotope behavior.